NCT06906380View on ClinicalTrials.gov

A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies

Not yet recruitingOBSERVATIONAL
Enrollment

49

Participants

Timeline

Start Date

May 7, 2025

Primary Completion Date

May 30, 2040

Study Completion Date

October 31, 2040

Conditions
Acute Myeloid Leukemia, in RelapseAcute Myeloid Leukemia, in Relapsed or RefractoryMDS (Myelodysplastic Syndrome)
Interventions
OTHER

Non interventional study

Non Intervention, an observation LTFU study

Sponsors
All Listed Sponsors
lead

ARCE Therapeutics, Inc.

INDUSTRY